A theme the specialists are building · as of 2026-10-26
Defensive Specialty Pharma
This trade reflects large-cap branded drug makers with use to specialty therapeutic adoption, pricing durability, and hospital/specialist channel demand.
19 proven specialist funds in3 stocks in the basket2 Consensus1 Early Conviction
LLYConsensusObesity, diabetes, oncology, neuroscience growth engine: one name revealed, on us
The other 2 names, each with its role and stage, are inside.See the basket with a free account →
Themes are read from quarterly filings of proven specialist funds plus the options tape. Evidence, not advice. Track our public record on The Book.